Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: An immunohistochemical analysis

Acta Histochemica

Volumn 105, Issue 3, 2003, Pages 245-252

  Mylonas, Ioannis ^a,b,c   Makovitzky, Josef ^b   Richter, Dagmar Ulrike ^b   Jeschke, Udo ^a   Briese, Volker ^b   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cathepsin D; Endometrium; Hyperplasia; Immunohistochemistry; Malignancy

Indexed keywords

HISTOLOGY; IMMUNOLOGY; PHYSIOLOGY;

IMMUNOSTAININGS;

TISSUE CULTURE;

ASPARTIC PROTEINASE; CATHEPSIN D;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYSOSOME; MALIGNANT TRANSFORMATION; MENSTRUAL CYCLE; PREMENOPAUSE; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0042378751     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1078/0065-1281-00715     Document Type: Article

References (35)

1. Ardavanis A, Gerakini F, Amanatidou A, Scorilas A, Pateras C, Garoufali A, Pissakas G, Stravolemos K, Apostolikas N, and Yiotis I (1997) Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance. Anticancer Res 17:3665-3669.
2. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M, and Rochefort H (1994) Characterization of the proximal estrogen-responsive element of human cathepsin-D gene. Mol Endocrinol 8: 693-703
3. Barrera C, Ye G, Espejo R, Gunasena S, Almanza R, Leary J, Crowe S, Ernst P, and Reyes VE (2001) Expression of cathepsins B, L, S, and D by gastric epithelial cells implicates them as antigen presenting cells in local immune responses. Hum Immunol 62: 1081-1091
4. Bergqvist A, Ferno M, and Mattson S (1996) A comparison of cathepsin-D levels in endometriotic tissue and in uterine endometrium. Fertil Steril 65: 1130-1134
5. Camier B, Hedon B, Rochefort H, and Maudelonde T (1996) Endometrial cathepsin-D immunostaining throughout ovulatory and anovulatory menstrual cycles. Hum Reprod 11: 392-397
6. Dallenbach-Hellweg G, and Poulsen H (1985) Atlas der Histopathologie des Endometriums. Springer, New York NY, USA
7. Diment S, Martin KJ, and Stahl PD (1989) Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 264: 13403-13406
8. Garcia M, Derocq D, Pujol P, and Rochefort H (1990) Overexpression of transfected cathepsin-D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5: 1809-1814
9. Garcia M, Platet N, Liaudet E, Laurent V, Derocq D, Brouillet JP, and Rochefort H (1996) Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells 14: 642-650
10. Inoue M (2001) Current molecular aspects of the carcinogenesis of the uterine endometrium. Int J Gynecol Cancer 11: 339-348
11. Inoue Y, Abe K, Obata K, Doh K, Ohmura G, Hoshiai H, and Noda K (1999) Immunohistochemical studies concerning cathepsin D in endometrial carcinomas. J Obstet Gynaecol Res 25: 345-352
12. Kagedal K, Johansson U, and Ollinger K (2001) The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15: 1592-1594
13. Lau TM, Affandi B, and Rogers PA (1996) Immunohistochemical detection of cathepsin D in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Mol Hum Reprod 2: 233-237
14. Losch A, Kohlberger P, Gitsch G, Kaider A, Breitenecker G, and Kainz C (1996) Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer 73: 1525-1528
15. Maudelonde T, Martinez P, Brouillet JP, Laffargue F, Pages A, and Rochefort H (1990) Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab 70: 115-121
16. Nasu K, Kai K, Fujisawa K, Takai N, Nishida Y, and Miyakawa I (2001) Expression of cathepsin L in normal endometrium and endometrial cancer. Eur J Obstet Gynecol Reprod Biol 99: 102-105
17. Nazeer T, Church K, Amato C, Ambros RA, Rosano TG, Malfetano JH, and Ross JS (1994) Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness. Mod Pathol 7: 469-474
18. Nazeer T, Malfetano JH, Rosano TG, and Ross JS (1992) Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol 97: 764-769
19. Nielsen AL, and Nyholm HC (1995) Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (ki-67 paraffin), cathepsin D, and C-erbB-2 protein (p185). Int J Gynecol Pathol 14: 230-234
20. Remmele W, and Sauer-Manthey J (1993) Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer. Virchows Arch A Pathol Anat Histopathol 422: 467-473
21. Remmele W, and Stegner HE (1987) Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8: 138-140
22. Rochefort H (1992) CathD in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 28A: 1780-1783
23. Rochefort H, Augereau P, Capony F, Garcia M, Cavailles V, Freiss G, Morisset M, and Vignon F (1988) The 52K cathepsin-D of breast cancer: structure, regulation, function and clinical value. Cancer Treat Res 40: 207-221
24. Rochefort H, Capony F, and Garcia M (1990) CathD in breast cancer: from molecular and cellular biology to clinical applications. Cancer Cells 2: 383-388
25. Rochefort H, Capony F, Garcia M, Cavailles V, Freiss G, Chambon M, Morisset M, and Vignon F (1987) Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem 35: 17-29
26. Rochefort H, Cavailles V, Augereau P, Capony F, Maudelonde T, Touitou I, and Garcia M (1989) Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem 34: 177-182
27. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, and von Figura K (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14: 3599-3608
28. Saygili U, Koyuncuoglu M, Altunyurt S, Guclu S, Uslu T, and Erten O (2001) May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study. Gynecol Oncol 83: 20-24
29. Scambia G, Benedetti P, Ferrandina G, Battaglia F, Baiocchi G, and Mancuso S (1991) CathD assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor. Br J Cancer 64: 182-184
30. Scambia G, Benedetti Panici P, Ferrandina G, Distefano M, Romanini ME, Sica G, and Mancuso S (1995) Significance of cathepsin-D expression in uterine tumours. Eur J Cancer 31A: 1449-1454
31. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rouesse J, and Rochefort H (1989) CathD: an independent prognostic factor for metastasis of breast cancer. Lancet 2: 1115-1118
32. Touitou I, Vignon F, Cavailles V, and Rochefort H (1991) Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines. J Steroid Biochem Mol Biol 40: 231-237
33. Van Noorden CJF, Jonges TGN, Meade-Tollin LC, Smith RE, and Köhler A (2000) In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants. Br J Cancer 82: 931-936
34. Van Noorden CJF, Meade-Tollin LC, and Bosman FT (1998) Metastasis. Am Sci 86: 130-141
35. Van Noort JM, and Van der Drift AC (1989) The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem 264: 14159-14164